Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded 2019 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Iambic Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Iambic Therapeutics Inc. market cap is $1.13B.
What is the 52-week high for Iambic Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Iambic Therapeutics Inc. 52 week high is $25.00 as of October 19, 2026.
What is the 52-week low for Iambic Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Iambic Therapeutics Inc. 52 week low is $16.00 as of October 19, 2026.
What is Iambic Therapeutics Inc. stock price today?
Iambic Therapeutics Inc. stock price today is $23.81.
What was Iambic Therapeutics Inc. stock price yesterday?
Iambic Therapeutics Inc. stock price yesterday was $18.91.
What is the 50-day moving average of Iambic Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Iambic Therapeutics Inc. 50-day moving average is $19.57.